PR-104 plus sorafenib in patients with advanced hepatocellular carcinoma.
Cancer chemotherapy and pharmacology.
Times cited: 9
- Phase II trial of idiotype vaccination in previously treated patients with indolent non-Hodgkin's lymphoma resulting in durable clinical responses. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Academic Article GET IT